BioNTech SE (BNTX) Free Cash Flow (2018 - 2025)
BioNTech SE's Free Cash Flow history spans 8 years, with the latest figure at $433.8 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 202.34% to $433.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$263.3 million, a 121.53% decrease, with the full-year FY2025 number at $713.0 million, up 35.02% from a year prior.
- Free Cash Flow hit $433.8 million in Q4 2025 for BioNTech SE, up from $42.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for BNTX hit a ceiling of $4.9 billion in Q3 2022 and a floor of -$769.8 million in Q1 2025.
- Historically, Free Cash Flow has averaged $974.2 million across 5 years, with a median of $263.7 million in 2021.
- Biggest five-year swings in Free Cash Flow: skyrocketed 2701.2% in 2022 and later plummeted 1470.98% in 2023.
- Tracing BNTX's Free Cash Flow over 5 years: stood at -$183.1 million in 2021, then surged by 638.01% to $985.4 million in 2022, then increased by 2.06% to $1.0 billion in 2023, then crashed by 142.15% to -$423.9 million in 2024, then soared by 202.34% to $433.8 million in 2025.
- Business Quant data shows Free Cash Flow for BNTX at $433.8 million in Q4 2025, $42.0 million in Q3 2025, and $30.7 million in Q2 2025.